These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2894124)

  • 21. Tardive dyskinesia and impaired glucose tolerance.
    Chong SA; Mythily ; Lum A; Huak CY; Kane J
    Hum Psychopharmacol; 2002 Aug; 17(6):305-7. PubMed ID: 12404676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs.
    Baldessarini RJ; Tarsy D
    Annu Rev Neurosci; 1980; 3():23-41. PubMed ID: 6106450
    [No Abstract]   [Full Text] [Related]  

  • 23. [Fluspirilene--safe weekly tranquilizer?].
    Kuhn W; Wöhrle M; Müller T; Welter F
    Nervenarzt; 1997 Jun; 68(6):528. PubMed ID: 9312689
    [No Abstract]   [Full Text] [Related]  

  • 24. Risk factors for drug-induced parkinsonism in tardive dyskinesia patients.
    Hansen TE; Brown WL; Weigel RM; Casey DE
    J Clin Psychiatry; 1988 Apr; 49(4):139-41. PubMed ID: 2895762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tardive dyskinesia: epidemiologic factors as a guide for prevention and management.
    Casey DE
    Adv Biochem Psychopharmacol; 1985; 40():15-24. PubMed ID: 2862762
    [No Abstract]   [Full Text] [Related]  

  • 26. [Tardive dyskinesia].
    Kato M; Watanabe K
    Ryoikibetsu Shokogun Shirizu; 2003; (38):183-7. PubMed ID: 12876961
    [No Abstract]   [Full Text] [Related]  

  • 27. Does long-acting injectable neuroleptic protect against tardive dyskinesia?
    Goldberg SC; Shenoy RS; Julius D; Hamer RM; Ross B; Minton T; Spiro M
    Psychopharmacol Bull; 1982 Oct; 18(4):177-9. PubMed ID: 6130561
    [No Abstract]   [Full Text] [Related]  

  • 28. Review of incidence studies of tardive dyskinesia associated with typical antipsychotics.
    Glazer WM
    J Clin Psychiatry; 2000; 61 Suppl 4():15-20. PubMed ID: 10739326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pathophysiologic basis of tardive dyskinesia.
    Baldessarini RJ
    Psychopharmacol Bull; 1978 Oct; 14(4):79-81. PubMed ID: 30114
    [No Abstract]   [Full Text] [Related]  

  • 30. Animal models of tardive dyskinesia--a review.
    Kulkarni SK; Naidu PS
    Indian J Physiol Pharmacol; 2001 Apr; 45(2):148-60. PubMed ID: 11480221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrating incidence and prevalence of tardive dyskinesia.
    Kane JM; Woerner M; Borenstein M; Wegner J; Lieberman J
    Psychopharmacol Bull; 1986; 22(1):254-8. PubMed ID: 2873613
    [No Abstract]   [Full Text] [Related]  

  • 32. Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy.
    Bitton V; Melamed E
    J Clin Psychiatry; 1984 Jan; 45(1):28-30. PubMed ID: 6141157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is there a presynaptic tardive dyskinesia?
    Bowers MB; Glazer WM
    J Clin Psychopharmacol; 1987 Feb; 7(1):57-9. PubMed ID: 2880877
    [No Abstract]   [Full Text] [Related]  

  • 34. Dogma disputed: is tardive dyskinesia due to postsynaptic dopamine receptor supersensitivity?
    Jeste DV; Wyatt RJ
    J Clin Psychiatry; 1981 Dec; 42(12):455-7. PubMed ID: 6118358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dose reduction of conventional antipsychotics: does it reduce tardive dyskinesia?].
    van Berkel M; Bogers JP; Bouvy PF
    Tijdschr Psychiatr; 2007; 49(1):37-41. PubMed ID: 17225204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tardive dyskinesia: a biological appraoch.
    Barbaccia ML; Trabucchi M
    Prog Clin Biol Res; 1980; 39():181-93. PubMed ID: 6105670
    [No Abstract]   [Full Text] [Related]  

  • 37. The lateralization of tardive dyskinesia.
    Wilson RL; Waziri R; Nasrallah HA; McCalley-Whitters M
    Biol Psychiatry; 1984 Apr; 19(4):629-35. PubMed ID: 6145451
    [No Abstract]   [Full Text] [Related]  

  • 38. [Tardive dyskinesia: a review].
    Crespo Facorro B; Payá González B; Ruiz Fernández V; Carbonell Masia C
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1997; 25(2):118-27. PubMed ID: 9245189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coping with a drug-induced movement disorder: tardive dyskinesia.
    Kane JM
    Geriatrics; 1982 Dec; 37(12):83-7. PubMed ID: 6128289
    [No Abstract]   [Full Text] [Related]  

  • 40. Patterns of psychotropic drug use and tardive dyskinesia.
    Branchey M; Branchey L
    J Clin Psychopharmacol; 1984 Feb; 4(1):41-5. PubMed ID: 6141189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.